nRichDX’s Post

“Breast cancer is much easier to treat before it spreads to other parts of the body, so it is vital to be able to detect signs of recurrence as early as possible to give people the best chance of survival. “It is very exciting to see advances in technology that can detect cancer cells and DNA with greater sensitivity to pick up residual disease or detect the early signs of breast cancer recurrence while a cure is still possible. These approaches are having a transformative effect on cancer diagnosis.” #breastcancer #cancer #recurrance #liquiddiagnosis #cancerresearch

Another one of our BRC's themes is Precision Diagnostics and Cancer Evolution. Our theme lead is Professor Nicholas Turner, and we aim to deliver on 4 key aims which you can read more about here: https://lnkd.in/e7Dt9wps Within the last year, a study in this theme has improved our understanding of an increasingly common complication of advanced breast cancer: https://lnkd.in/eJ3YPsi7 Additionally, scientists have developed a new way of using cancers' DNA to spot cancer patients who may benefit from immunotherapy: https://lnkd.in/e2gjr_wE #FutureofCancer

Did you know breast cancer is the most common form of disease worldwide? While there are preventative tests for women and men to capture signs of breast cancer early, for some, it still can be too late. This new "ultra-sensitive" blood test is truly groundbreaking in that regard - helping to predict if breast cancer will return years before the disease shows up on scans, allowing treatment to start earlier and improve survival rates. While the journey to widespread availability may be complex, the implications of this advancement are profound. I eagerly anticipate the day when this test becomes a standard tool in the fight against breast cancer, offering hope and improved outcomes globally. #BreastCancer #BloodTest #ResearchBreakthrough

As CNN reports, researchers are looking to blood-based biomarkers as an innovative early detection tool for pancreatic cancer. Dr. Brian Wolpin, director of the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, explains that the lack of screening tests means too many patients are being diagnosed in the later, more lethal stages of this disease. “The more patients we can find early, the greater the chance we have to cure patients of pancreatic cancer and start to reverse the statistics.” These sentiments are exactly why we are proudly investing in MD Anderson Cancer Center's study that is harnessing AI to integrate imaging and blood-based biomarkers. Learn more: https://lnkd.in/gyp_36Cb #pancreaticcancer #cancerresearch #cancerscreening #earlydetection

⭐ Amazing research from The Institute of Cancer Research who have developed an 'ultra sensitive' blood test which can predict the return of breast cancer years before being detected by scans. The test detects traces of a tumour's DNA before a complete relapse and has been proven to be 100% accurate in predicting which patients will experience a recurrence of their cancer. The trial is still in its only stages, having only tested 78 patients, however it provides great hope that the early identification of recurrent breast cancer lies in a not too distant future. #diagnostics #breastcancer #bloodtests #earlydiagnosis https://lnkd.in/dsrzrZxm

Breakthrough Blood Test Predicts Breast Cancer Comeback 🧬 A groundbreaking blood test can now predict the return of breast cancer, promising earlier interventions and better patient outcomes. This innovation highlights the power of precision medicine. No one wants to hear that their cancer has returned, however, the ability to conduct more frequent blood tests can lead to earlier detection and better outcomes for many. At 8Mile, we’re excited about tech-driven healthcare advancements. How do you think this will impact patient care in the future? Share your thoughts below! #healthcareinnovation #breastcancer #precisionmedicine #8mile #singapore https://lnkd.in/gjVrCfQE

A colonoscopy detects for colorectal cancer, but #didyouknow it can also detect for signs at a pre-cancer stage? "We know there is a continuum, where the developmental process can take a decade or longer. Therefore when I speak to my patients about screening for colon cancer, I'm trying to detect the pre-cursor of cancer and nip it in the bud," shared Dr Samuel Ow, Senior Consultant, Department of Haematology-Oncology, NCIS. Click below to read Dr Ow's full sharing about cancer screening: https://lnkd.in/g6a2vcqk

“What . . . has (been) discovered is a key protein that's secreted from CAFs in breast cancer brain metastases and that increases the invasive capacity of the cancer cells. This secreted protein, if it makes it to circulation, could potentially represent a new liquid biopsy test, which may hopefully be [able to detect brain metastases] faster and earlier than current screening approaches. #mrd #breastcancer #liquidbiopsy #precisionmedicine #cancerresearch #precisiononcology #cancer #genomics #wgs

Because triple-negative breast cancer is an especially aggressive breast cancer subtype with fewer targeted treatment options, BCRF has long recognized the urgent need for more research. BCRF investigators have been integral to many of these advancements and their engagement in clinical trials now—and, no doubt, in the future—will keep propelling TNBC research forward. To read more about how research is turning the tide on TNBC, click the link below. https://bit.ly/3pwxDMF

The second article of my doctoral thesis is now published at Cancer Cell International! 🏖 Our group found Collagen type VII as a potential new biomarker in breast cancer as it was associated to lower proliferation. This is only a scratch on the surface on understanding the intricate ways of the tumour microenvironment in breast cancer and I am excited to continue working on this lead. You can find the full-text in the link below. https://lnkd.in/dUJ-aZhi.